Chronic kidney disease has long been treated most aggressively when it stems from diabetes, the condition behind a large ...

People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says. Women with diabetes and kidney disease will develop heart problems 26 years earlier, ...

STOCKHOLM — Improvements in kidney function outcomes observed with glucagon-like peptide-1 (GLP-1) receptor agonists in patients with type 2 diabetes extend to patients who are overweight or obese but ...

Microalbuminuria (a high albumin level in your urine) is often a marker of diabetic nephropathy (kidney disease). Since microalbuminuria often doesn’t cause symptoms, experts recommend seeing a doctor ...

Diabetic nephropathy is kidney damage caused by diabetes that often progresses slowly. Many people notice few or no symptoms until later stages. Early symptoms can begin in stage 2, when the ...

Share on Pinterest Ozempic shows promise in delaying chronic kidney disease progression, Novo Nordisk announced. Image credit: Jaap Arriens/NurPhoto via Getty Images. Type 2 diabetes is a condition ...

A detailed new map of the human kidney revealed a previously unrecognized form of diabetic kidney disease (DKD) marked by clusters of immune cells—specifically B cells—that are linked to faster ...

When kidney function declines to around 10%, the body can no longer remove waste products efficiently, maintain fluid balance ...

Share on Pinterest Chronic kidney disease and type 2 diabetes are linked to a heightened cardiovascular disease risk. PER Images/Stocksy A new study suggests that people with chronic kidney disease, ...

Around 9 in 10 Americans with chronic kidney disease do not know they have it.

As glucagon-like peptide-1 (GLP-1) receptor agonists become increasingly popular medications used to treat both type 2 diabetes and obesity, the question is raised: How do GLP-1s impact kidney health?